Your browser doesn't support javascript.
loading
Novel self-sampling culture method to monitor excretion of live, oral Shigella flexneri 2a vaccine SC602 during a community-based phase 1 trial.
Teska, J D; Coster, T; Byrne, W R; Colbert, J R; Taylor, D; Venkatesan, M; Hale, T L.
Affiliation
  • Teska JD; Geo-Centers Inc, Fort Detrick, Maryland, USA.
J Lab Clin Med ; 134(2): 141-6, 1999 Aug.
Article in En | MEDLINE | ID: mdl-10444027
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Shigella flexneri / Bacterial Vaccines / Dysentery, Bacillary / Feces Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Lab Clin Med Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Shigella flexneri / Bacterial Vaccines / Dysentery, Bacillary / Feces Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Lab Clin Med Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos